FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)

View source ↗

Summary

The FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) submitted by Cephalon, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Treanda (Bendamustine)

Snippet

SUPPL AP for TREANDA (BENDAMUSTINE HYDROCHLORIDE)